Nitric oxide-donor/PARP-inhibitor combination: A new approach for sensitization to ionizing radiation
Wilson A, Menon V, Khan Z, Alam A, Litovchick L, Yakovlev V. Nitric oxide-donor/PARP-inhibitor combination: A new approach for sensitization to ionizing radiation. Redox Biology 2019, 24: 101169. PMID: 30889466, PMCID: PMC6423503, DOI: 10.1016/j.redox.2019.101169.Peer-Reviewed Original ResearchConceptsPARP inhibitorsBRCA1/2 mutationsSingle agentTumor microenvironmentAdditional therapeutic benefitBRCA1 expressionNew drug combinationsDNA-damaging therapiesNon-toxic concentrationsTumor-targeting approachesCancer patientsOvarian cancerBreast cancerDrug combinationsTherapeutic benefitClinical developmentTumorsRadiation treatmentCancerOxidative stressSubsequent inhibitionSynthetic lethality approachSensitizationHigh potencyDNA damage